Orthopedic Surgery

Healio revisits the trending orthopedics news, research and topics from our staff’s meeting news coverage in 2022.

Healio highlights the monthly Cover Stories of Orthopedics Today that were published in 2022.

Healio highlights the most impactful research, news and advancements in orthopedics from the year.

Tranexamic acid vs. placebo for life-threatening, major and critical organ bleeding in patients undergoing noncardiac surgery.

WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for life-threatening, major and critical organ bleeding compared with placebo, according to results of the POISE-3 trial.

SAN DIEGO — Pediatric patients used significantly fewer narcotic doses after common orthopedic surgeries than the quantities prescribed, according to results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.

The volume of visits for pediatric fractures decreased by 2.5 fold during the COVID-19 pandemic at one pediatric trauma hospital, mostly due to a decrease in playground use and less participation in organized sports, researchers said.

Rivaroxaban (Xarelto, Janssen/Bayer) vs. enoxaparin for prevention of venous thromboembolism during immobilization after lower-limb nonmajor orthopedic surgery.

By no means has it been business as usual for the orthopedic surgery industry amid the COVID-19 pandemic. Companies, regulatory agencies and other organizations have had to respond to the COVID-19 pandemic in myriad ways that have required them to be innovative and more business savvy than ever.

As the COVID-19 pandemic has presented challenges for businesses and organizations around the world, the president of the American Academy of Orthopaedic Surgeons said these unprecedented times can present opportunities for progressing the AAOS member experience, to strive for strategic goals and to grow as an organization.